Hisatsune, Y., Nakano, H., Mihara, Y., Tobe, N., Ishibashi, K., Shimamura, T., . . . Otsubo, T. (2013). A patient who showed a pathologically complete response after undergoing treatment with XELOX plus bevacizumab for synchronous liver metastasis of grade H2 from sigmoid colon cancer. Pioneer Bioscience Publishing Company.
Styl ChicagoHisatsune, Yasuhito, Hiroshi Nakano, Yoshitaka Mihara, Naotaka Tobe, Kazuyoshi Ishibashi, Tsukasa Shimamura, Kei-ichi Tanaka, Yoshio Aida, a Takehito Otsubo. A Patient Who Showed a Pathologically Complete Response After Undergoing Treatment With XELOX Plus Bevacizumab for Synchronous Liver Metastasis of Grade H2 From Sigmoid Colon Cancer. Pioneer Bioscience Publishing Company, 2013.
Citace podle MLAHisatsune, Yasuhito, et al. A Patient Who Showed a Pathologically Complete Response After Undergoing Treatment With XELOX Plus Bevacizumab for Synchronous Liver Metastasis of Grade H2 From Sigmoid Colon Cancer. Pioneer Bioscience Publishing Company, 2013.